Concerns Over Botox Safety
February 10, 2008 by MedHeadlines
Filed under Cerebral Palsy, Children's Health, Cosmetic Surgery, Drugs, FDA
The FDA has issued a statement notifying the public about systemic adverse reactions caused by Botox, Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B). Systemic adverse reactions have been linked to a variety of treatments, both approved and unapproved by the FDA, and a wide range of doses. Reported incidents had presentation similar to botulism, in which botulinum toxin spreads throughout the body. Read more
Loading ...
